Family · Pharmaceutical analytical standards
Edaravone
An antioxidant that neutralises free radicals, used in Japan since 2001 for stroke and later also approved for amyotrophic lateral sclerosis (ALS), in Japan in 2015. This family brings together metabolites, labelled standards and other impurities.
Did you know?In 2017 it became the first new ALS medicine approved by the FDA in 22 years: the previous one was riluzole, in 1995.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
